---
title: 'Medicine ğŸŠâ­'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Cardiovascular Medicine / å¾ªç’°å™¨å†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Ischemic Heart Disease / è™šè¡€æ€§å¿ƒç–¾æ‚£
Angina pectoris \\
Myocardial infarction \\
Chronic ischemic heart disease \\
Sudden cardiac death

### Valvular Heart Disease / å¼è†œç—‡
Calcific aortic stenosis \\
Mitral valve prolapse \\
Rheumatic heart disease \\
Infective endocarditis \\
Nonbacterial thrombotic endocarditis

### Cardiomyopathy / å¿ƒç­‹ç—‡
Dilated cardiomyopathy \\
Hypertrophic cardiomyopathy \\
Restrictive cardiomyopathy \\
Myocarditis

### Pericardial Disease / å¿ƒè†œç–¾æ‚£
Acute pericarditis \\
Cardiac tamponade \\
Constrictive pericarditis

### Cardiac Tumor / å¿ƒè‡“è…«ç˜
Myxoma \\
Papillary fibroelastoma \\
Rhabdomyoma \\
Metastatic tumor

### Congenital Heart Disease / å…ˆå¤©æ€§å¿ƒç–¾æ‚£
Ventricular septal defect \\
Atrial septal defect \\
Patent ductus arteriosus \\
Tetralogy of fallot \\
Transposition of the great arteries \\
Tricuspid atresia \\
Coarctation of the aorta \\
Pulmonary stenosis\\
Aortic stenosis

### Heart Failure / å¿ƒä¸å…¨
Left-sided heart failure \\
Right-sided heart failure

### Arterial Disorder / å‹•è„ˆç–¾æ‚£
Atherosclerosis \\
Arteriolosclerosis \\
MÃ¶nckeberg's sclerosis \\
Abdominal aortic aneurysm \\
Thoracic aortic aneurysm \\
Aortic dissection
Hypertension

### Venous Disorder / é™è„ˆç–¾æ‚£
Varicose vein \\
Deep vein thrombosis \\
Superior vena cava syndrome \\
Lymphedema

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Ischemic Heart Disease / è™šè¡€æ€§å¿ƒç–¾æ‚£

## Valvular Heart Disease / å¿ƒå¼è†œç—‡

## Endocardium, Myocardium, and Pericardium Disorders / å¿ƒå†…è†œãƒ»å¿ƒç­‹ãƒ»å¿ƒè†œç–¾æ‚£

## Arrhythmia / ä¸æ•´è„ˆ

## Arterial Disorders / å‹•è„ˆç–¾æ‚£

## Venous Disorders / é™è„ˆç–¾æ‚£

## Blood Pressure Abnormalities / è¡€åœ§ç•°å¸¸

# Respiratory Medicine / å‘¼å¸å™¨å†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Infectious Diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Obstructive Lung Diseases / é–‰å¡æ€§è‚ºç–¾æ‚£

## Interstitial Lung Diseases / é–“è³ªæ€§è‚ºç–¾æ‚£

## Immune and Allergic Diseases / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§ç–¾æ‚£

## Pulmonary Vascular Disorders / è‚ºå¾ªç’°éšœå®³

## Lung Tumors / è‚ºè…«ç˜

## Lungs and Bronchi Abnormalities / è‚ºãƒ»æ°—ç®¡æ”¯ã®å½¢æ…‹ç•°å¸¸

## Functional Respiratory Disorders / æ©Ÿèƒ½çš„å‘¼å¸éšœå®³

## Mediastinal Disorders / ç¸¦éš”ç–¾æ‚£

## Pleural and Chest Wall Disorders / èƒ¸è†œãƒ»èƒ¸å£ç–¾æ‚£

# Gastroenterology / æ¶ˆåŒ–å™¨å†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Esophageal Disorders / é£Ÿé“ç–¾æ‚£

## Gastric and Duodenal Disorders / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜

## Intestine and Anal Disorders / è…¸ãƒ»è‚›é–€ç–¾æ‚£

## Diaphragm and Abdominal Wall Disorders / æ¨ªéš”è†œãƒ»è…¹å£ç–¾æ‚£

## Liver Disorders / è‚ç–¾æ‚£

## Biliary System Disorders / èƒ†é“ç³»ç–¾æ‚£

## Pancreas Disorders / è†µç–¾æ‚£

# Nephrology / è…è‡“å†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Nephritic Syndrome / è…ç‚ç—‡å€™ç¾¤
Acute proliferative glomerulonephritis \\
Crescentic glomerulonephritis \\
IgA nephropathy \\
Alport syndrome \\
Thin basement membrane nephropathy

### Nephrotic Syndrome / ãƒãƒ•ãƒ­ãƒ¼ã‚¼ç—‡å€™ç¾¤
Membranous nephropathy \\
Minimal change disease \\
Focal segmental glomerulosclerosis \\
Membranoproliferative glomerulonephritis \\
Dense deposit disease \\
Fibrillary Glomerulonephritis

### Glomerular Lesion Associated With Systemic Disease / å…¨èº«ç–¾æ‚£ã«ä¼´ã†ç³¸çƒä½“ç–¾æ‚£
Lupus Nephritis \\
Henoch-SchÃ¶nlein Purpura \\
Diabetic Nephropathy \\
Cryoglobulinemic Nephropathy \\
Amyloidosis

### Tubulointerstitial Disease / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£
Acute tubular injury \\
Acute pyelonephritis \\
Chronic pyelonephritis \\
Acute drug-induced interstitial nephritis \\
Urate nephropathy \\
Nephrocalcinosis \\
Light-chain cast nephropathy \\
Autosomal dominant tubulointerstitial kidney disease \\
Bile cast nephropathy \\

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Glomerular Disorders / ç³¸çƒä½“ç–¾æ‚£

## Tubulointerstitial Disorders / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£

## Renal Disorders with Systemic Diseases / å…¨èº«ç–¾æ‚£ã«ä¼´ã†è…éšœå®³

## Renal Vascular Disorders / è…å¾ªç’°éšœå®³

## Stones and Tumors / çµçŸ³ã¨è…«ç˜

## Infections / æ„ŸæŸ“ç—‡

## Functional Disorders / æ©Ÿèƒ½éšœå®³

## Water and Electrolyte Metabolism Disorders / æ°´ãƒ»é›»è§£è³ªä»£è¬ç•°å¸¸

# Endocrinology and Metabolism / å†…åˆ†æ³Œãƒ»ä»£è¬å†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Pituitary Disorder / ä¸‹å‚ä½“ç–¾æ‚£
Pituitary adenoma \\
Lactotroph adenoma \\
Somatotroph adenoma \\
Corticotroph adenoma \\
Hypopituitarism \\
Diabetes insipidus \\
Syndrome of inappropriate ADH secretion

### Thyroid Disorder / ç”²çŠ¶è…ºç–¾æ‚£
Graves disease \\
Hashimoto thyroiditis \\
Painless thyroiditis \\
Subacute thyroiditis \\
Simple goiter \\
Multinodular goiter \\
Thyroid adenoma \\
Papillary carcinoma \\
Follicular carcinoma \\
Anaplastic carcinoma \\
Medullary carcinoma \\
Thyroglossal duct cyst

### Parathyroid Disorder / å‰¯ç”²çŠ¶è…ºç–¾æ‚£
Primary hyperparathyroidism \\
Secondary hyperparathyroidism \\
Hypoparathyroidism

### Adrenal Gland Disorder / å‰¯è…ç–¾æ‚£
Hyperaldosteronism \\
Cushing syndrome \\
Congenital adrenal hyperplasia \\
Acute adrenocortical insufficiency \\
Addison disease \\
Adrenocortical neoplasm \\
Pheochromocytoma

### Endocrine Pancreatic Disorder / å†…åˆ†æ³Œè†µè‡“ç–¾æ‚£
Type 1 diabetes mellitus \\
Type 2 diabetes mellitus \\
Chronic complications of diabetes \\
Pancreatic neuroendocrine tumor \\
Insulinoma \\
Gastrinoma

### Other Endocrine Disorder / ãã®ä»–ã®å†…åˆ†æ³Œç–¾æ‚£
Multiple endocrine neoplasia type 1 \\
Multiple endocrine neoplasia type 2

## Pharmacology / è–¬ç†

### Hypothalamic Hormone / è¦–åºŠä¸‹éƒ¨ãƒ›ãƒ«ãƒ¢ãƒ³
Somatostatin analog: Octreotide, lanreotide \\
Gonadotropin-releasing hormone agonist: Leuprolide, goserelin, buserelin, histrelin, nafarelin, triptorelin \\
Gonadotropin-releasing hormone antagonist: Ganirelix, cetrorelix, degarelix \\
Dopamine agonist: Bromocriptine, cabergoline

### Anterior Pituitary Hormone / ä¸‹å‚ä½“å‰è‘‰ãƒ›ãƒ«ãƒ¢ãƒ³
Growth hormone analog: Somatropin \\
Growth hormone receptor antagonist: Pegvisomant \\
Follicle-stimulating hormone analog: Follitropin alfa, follitropin beta, urofollitropin, menotropin \\
Luteinizing hormone analog: Human chorionic gonadotropin \\

### Posterior Pituitary Hormones / ä¸‹å‚ä½“å¾Œè‘‰ãƒ›ãƒ«ãƒ¢ãƒ³
Vasopressin receptor agonist: Desmopressin, vasopressin \\
Vasopressin receptor antagonist: Conivaptan, tolvaptan \\
Oxytocin

### Thyroid Hormone / ç”²çŠ¶è…ºãƒ›ãƒ«ãƒ¢ãƒ³
Thyroid hormone: Levothyroxine, liothyronine \\
Thioamide: Methimazole, propylthiouracil \\
Iodide: Lugol's solution, potassium iodide \\
Radioactive iodine I-131: Sodium iodide I-131

### Corticosteroid / å‰¯è…çš®è³ªãƒ›ãƒ«ãƒ¢ãƒ³
Glucocorticoid: Hydrocortisone \\
Mineralocorticoid: Fludrocortisone \\
Adrenocortical antagonist: Mitotane, metyrapone, ketoconazole

### Glucose Homeostasis / ã‚°ãƒ«ã‚³ãƒ¼ã‚¹æ’å¸¸æ€§
Insulin: Insulin lispro, insulin aspart, insulin glulisine / regular insulin / insulin NPH / insulin detemir, insulin glargine, insulin degludec \\
Sulfonylurea: Chlorpropamide, tolbutamide, tolazamide / glipizide, gliclazide, glimepiride, glyburide \\
Meglitinide: Repaglinide, nateglinide, mitiglinide \\
GLP-1 agonist: Exenatide, liraglutide, lixisenatide, albiglutide, dulaglutide \\
DPP-4 inhibitor: Sitagliptin, saxagliptin, linagliptin, alogliptin, vildagliptin \\
Biguanide: Metformin \\
Thiazolidinedione: Pioglitazone, rosiglitazone \\
Î±-Glucosidase inhibitor: Acarbose, voglibose, miglitol \\
SGLT2 inhibitor: Canagliflozin, dapagliflozin, empagliflozin \\
Amylin analog: Pramlintide

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Hypothalamus and Pituitary Disorders / è¦–åºŠä¸‹éƒ¨ãƒ»ä¸‹å‚ä½“ç–¾æ‚£

## Thyroid Disorders / ç”²çŠ¶è…ºç–¾æ‚£

## Parathyroid Disorders / å‰¯ç”²çŠ¶è…ºç–¾æ‚£

## Adrenal Gland disorders / å‰¯è…ç–¾æ‚£

## Other Endocrine Disorders / ãã®ä»–ã®å†…åˆ†æ³Œç–¾æ‚£

## Carbohydrate Metabolism Disorders / ç³–è³ªä»£è¬ç•°å¸¸

## Lipid Metabolism Disorders / è„‚è³ªä»£è¬ç•°å¸¸

## Amino Acid Metabolism Disorders / ã‚¢ãƒŸãƒé…¸ä»£è¬ç•°å¸¸

## Other Metabolic Disorders / ãã®ä»–ã®ä»£è¬ç•°å¸¸

## Nutritional Abnormalities / æ „é¤Šã®ç•°å¸¸

# Hematology and Oncology / è¡€æ¶²ãƒ»è…«ç˜å†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

### Nonhemolytic Anemia / éæº¶è¡€æ€§è²§è¡€

* **Iron deficiency anemia**
  * Concept: The most common type of anemia globally, caused by inadequate iron to synthesize hemoglobin.
  * Pathogenesis: Results from inadequate dietary intake, absorption issues, or blood loss leading to depleted iron stores and decreased hemoglobin synthesis.
  * Morphology: Microcytic, hypochromic red blood cells.
  * Clinical: Symptoms include fatigue, pallor, weakness, and in severe cases, spoon-shaped nails and pica.
* **Anemia of chronic disease**
  * Concept: Anemia associated with chronic infections, inflammatory diseases, or malignancies.
  * Pathogenesis: Cytokines and inflammatory responses inhibit iron metabolism and erythropoiesis.
  * Morphology: Normocytic, normochromic or slightly microcytic, hypochromic red blood cells.
  * Clinical: Typically mild to moderate severity with symptoms overshadowed by the underlying disease.
* **Sideroblastic anemia**
  * Concept: Characterized by the presence of ringed sideroblasts in the bone marrow.
  * Pathogenesis: Caused by defective protoporphyrin synthesis leading to iron-loaded mitochondria around the nucleus of developing red cells.
  * Morphology: Presence of ring sideroblasts in the bone marrow; red blood cells may appear hypochromic and microcytic.
  * Clinical: Symptoms include fatigue, splenomegaly, and sometimes signs of iron overload.
* **Megaloblastic anemia (Vitamin B12 deficiency)**
  * Concept: Anemia due to insufficient vitamin B12, crucial for DNA synthesis.
  * Pathogenesis: Commonly due to malabsorption (e.g., pernicious anemia), dietary deficiency is rare except in strict vegetarians.
  * Morphology: Macrocytic red blood cells with hypersegmented neutrophils.
  * Clinical: Neurological symptoms such as numbness, tingling, and balance issues, in addition to fatigue and weakness.
* **Megaloblastic anemia (Folate deficiency)**
  * Concept: Caused by inadequate folate, essential for DNA and RNA synthesis.
  * Pathogenesis: Often results from poor diet, malabsorption, or medications that interfere with folate metabolism.
  * Morphology: Similar to vitamin B12 deficiency with macrocytic red cells.
  * Clinical: Symptoms include fatigue, weakness, and gastrointestinal distress without the neurological symptoms seen in B12 deficiency.
* **Aplastic anemia**
  * Concept: A rare disorder characterized by bone marrow failure.
  * Pathogenesis: Can be idiopathic, or due to exposure to toxins, radiation, or certain medications; immune-mediated destruction of hematopoietic cells may occur.
  * Morphology: Pancytopenia with a hypocellular bone marrow.
  * Clinical: Presents with symptoms of pancytopenia such as fatigue, bleeding, and increased susceptibility to infections.
* **Pure red cell aplasia**
  * Concept: Rare condition characterized by a severe reduction in red cell precursors in the bone marrow.
  * Pathogenesis: Often idiopathic or associated with autoimmune disorders, lymphoproliferative disorders, or thymomas.
  * Morphology: Normocytic, normochromic red cells, but very few reticulocytes; bone marrow shows a selective absence of red cell precursors.
  * Clinical: Severe anemia with reticulocytopenia but normal white cell and platelet counts.
{: .notice--info}

### Hemolytic Anemia / æº¶è¡€æ€§è²§è¡€

* **Hereditary spherocytosis**
  * Concept: A genetic disorder that causes a defect in the red blood cell membrane, leading to spherical, fragile erythrocytes.
  * Pathogenesis: Mutations affect proteins in the RBC membrane, particularly spectrin, causing cells to lose their biconcave shape and become spherical.
  * Morphology: Spherocytes with a loss of central pallor in the red cells.
  * Clinical: Symptoms include anemia, jaundice, splenomegaly, and a high risk of gallstones.
* **Thalassemia**
  * Concept: A genetic disorder resulting in reduced or absent synthesis of one of the globin chains in hemoglobin.
  * Pathogenesis: Mutations in the genes encoding alpha or beta globin chains lead to imbalanced globin synthesis and ineffective erythropoiesis.
  * Morphology: Microcytic, hypochromic red cells, often with target cells and poikilocytosis.
  * Clinical: Varies from mild anemia with minor symptoms to severe anemia requiring regular transfusions, splenomegaly, and iron overload.
* **Sickle cell disease**
  * Concept: A genetic disease where red blood cells assume a sickle shape under low oxygen conditions.
  * Pathogenesis: Mutation in the beta-globin gene causes hemoglobin S (HbS), which polymerizes under low oxygen, distorting the red cell shape.
  * Morphology: Sickled erythrocytes with elongated and pointed shapes.
  * Clinical: Painful crises, acute chest syndrome, chronic hemolytic anemia, and potential organ damage.
* **G6PD deficiency**
  * Concept: A hereditary enzyme deficiency that leads to episodic hemolytic anemia.
  * Pathogenesis: Deficiency in glucose-6-phosphate dehydrogenase, which helps protect red blood cells from oxidative damage.
  * Morphology: Normal until exposed to oxidative stress; then bite cells and blister cells appear.
  * Clinical: Episodes of acute hemolytic anemia triggered by infections, certain drugs, or foods like fava beans.
* **Paroxysmal nocturnal hemoglobinuria**
  * Concept: An acquired clonal hematopoietic disorder that leads to the increased destruction of red blood cells.
  * Pathogenesis: Mutation in the PIGA gene, affecting the cell's ability to anchor proteins that protect against complement-mediated destruction.
  * Morphology: Varied red cell appearance, generally normal until hemolysis occurs.
  * Clinical: Episodic dark urine, hemoglobinuria, thrombosis, and bone marrow failure.
* **Autoimmune hemolytic anemia**
  * Concept: Anemia caused by autoantibodies targeting and destroying red blood cells.
  * Pathogenesis: Immune system produces antibodies against red cell antigens, leading to their premature destruction.
  * Morphology: Spherocytes due to partial phagocytosis by macrophages in the spleen.
  * Clinical: Symptoms of anemia with possible jaundice; severity can range from mild to life-threatening.
* **Microangiopathic anemia**
  * Concept: Anemia resulting from the mechanical destruction of red blood cells as they pass through narrowed or damaged small blood vessels.
  * Pathogenesis: Occurs in conditions like disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), or hemolytic uremic syndrome (HUS).
  * Morphology: Schistocytes (fragmented red cells) present in blood smear.
  * Clinical: Anemia accompanied by other signs of the underlying disorder, such as thrombocytopenia, renal failure, or neurological symptoms.
* **Macroangiopathic anemia**
  * Concept: Anemia caused by physical trauma to red blood cells due to abnormal blood flow through large blood vessels.
  * Pathogenesis: Typically occurs in the presence of artificial heart valves or other vascular abnormalities causing high shear stress.
  * Morphology: Fragmented red cells and signs of hemolysis.
  * Clinical: Symptoms of anemia and may include signs of hemolysis such as jaundice and elevated lactate dehydrogenase (LDH).
{: .notice--info}

### Leukemia / ç™½è¡€ç—…

* **Acute myeloid leukemia**
  * Concept: A rapid-progressing form of leukemia characterized by the accumulation of immature myeloid cells in the bone marrow.
  * Pathogenesis: Caused by mutations in the DNA of developing cells in the bone marrow, which interfere with cell maturation and lead to proliferation of immature blasts.
  * Morphology: Presence of myeloblasts with Auer rods in the bone marrow.
  * Clinical: Symptoms include fatigue, easy bruising and bleeding, and increased risk of infection.
* **Acute lymphoblastic leukemia**
  * Concept: A fast-growing type of leukemia that occurs when the bone marrow makes too many immature lymphocytes.
  * Pathogenesis: Genetic alterations lead to the transformation of lymphoid progenitor cells into malignant lymphoblasts that proliferate rapidly.
  * Morphology: Overproduction of lymphoblasts in bone marrow.
  * Clinical: Presents with fever, bleeding, bone pain, and lymphadenopathy; common in children.
* **Chronic myeloid leukemia**
  * Concept: A type of leukemia characterized by excessive development of granulocytes in the bone marrow.
  * Pathogenesis: Associated with the Philadelphia chromosome, resulting in the BCR-ABL fusion gene, which drives the overproduction of these cells.
  * Morphology: Increased granulocytes in various stages of maturation; very high white blood cell counts.
  * Clinical: Often asymptomatic in early stages; later stages include fatigue, weight loss, and splenomegaly.
* **Chronic lymphocytic leukemia**
  * Concept: A slow-growing leukemia that predominantly affects older adults, characterized by the accumulation of functionally incompetent lymphocytes.
  * Pathogenesis: Usually arises from a monoclonal population of B cells that have escaped apoptosis.
  * Morphology: Predominance of small, mature lymphocytes in peripheral blood, marrow, and lymphoid tissues.
  * Clinical: Often asymptomatic; can present with lymphadenopathy, anemia, and susceptibility to infections.
* **Hairy cell leukemia**
  * Concept: A rare, slow-growing leukemia of B cells characterized by cells with hair-like projections.
  * Pathogenesis: Malignant B cells have mutations that lead to uncontrolled growth, often involving the BRAF gene.
  * Morphology: Unique "hairy" appearance of the leukemic cells.
  * Clinical: Symptoms include splenomegaly, pancytopenia, and recurrent infections.
* **Adult T-cell leukemia/lymphoma**
  * Concept: A rare and often aggressive type of leukemia caused by human T-cell lymphotropic virus type 1 (HTLV-1).
  * Pathogenesis: HTLV-1 integration into T-cell DNA results in clonal expansion and transformation of T-cells.
  * Morphology: Proliferation of mature CD4+ T-cells, which can appear abnormal.
  * Clinical: Can present with skin lesions, lymphadenopathy, hypercalcemia, and a poor prognosis depending on the subtype.
{: .notice--info}

### Lymphoma / ãƒªãƒ³ãƒ‘è…«

* **Hodgkin lymphoma**
  * Concept: A type of lymphoma characterized by the presence of Reed-Sternberg cells.
  * Pathogenesis: The exact cause is unclear, but it often involves genetic mutations and Epstein-Barr virus infection.
  * Morphology: Presence of large, abnormal Reed-Sternberg cells within a reactive cell infiltrate.
  * Clinical: Symptoms include painless lymphadenopathy, night sweats, fever, and weight loss.
* **Diffuse large B-cell lymphoma**
  * Concept: The most common form of non-Hodgkin lymphoma, characterized by rapidly growing tumors made of large B cells.
  * Pathogenesis: Arises from genetic mutations that lead to uncontrolled B cell proliferation.
  * Morphology: Large lymphoid cells with a diffuse growth pattern.
  * Clinical: Rapidly enlarging lymph node or mass, often associated with systemic symptoms.
* **Follicular lymphoma**
  * Concept: A usually indolent non-Hodgkin lymphoma that arises from follicle center (germinal center) B cells.
  * Pathogenesis: Frequently associated with the t(14;18) translocation involving the BCL2 gene.
  * Morphology: Neoplastic follicles dispersed throughout affected tissues, mimicking normal lymph node architecture.
  * Clinical: Slowly progressive lymphadenopathy, often asymptomatic for long periods.
* **MALT lymphoma**
  * Concept: Mucosa-associated lymphoid tissue lymphoma, often associated with chronic inflammatory diseases, such as H. pylori gastritis.
  * Pathogenesis: Chronic inflammation leads to lymphoid proliferation and eventual lymphoma development.
  * Morphology: Lymphoma cells infiltrate mucosal tissues forming lymphoepithelial lesions.
  * Clinical: Depending on location, symptoms may involve pain or dysfunction of the affected organ (e.g., stomach, salivary glands).
* **Mantle cell lymphoma**
  * Concept: A rare, aggressive type of non-Hodgkin lymphoma characterized by small to medium-sized B cells originating from the mantle zone.
  * Pathogenesis: Hallmarked by the t(11;14) translocation, resulting in overexpression of cyclin D1.
  * Morphology: Monomorphic lymphocytes with irregular nuclear contours.
  * Clinical: Presents with extensive lymphadenopathy, splenomegaly, and often bone marrow involvement.
* **Burkitt lymphoma**
  * Concept: A highly aggressive B-cell lymphoma associated with Epstein-Barr virus, characterized by a high degree of proliferation of the malignant cells.
  * Pathogenesis: Characterized by translocation involving the MYC gene, leading to its overexpression.
  * Morphology: "Starry sky" appearance due to interspersed macrophages among rapidly dividing lymphocytes.
  * Clinical: Presents with rapidly enlarging mass, often in the abdomen or jaw; more common in children and young adults.
* **Peripheral T-cell lymphoma, unspecified**
  * Concept: A diverse group of aggressive lymphomas that arise from mature T cells.
  * Pathogenesis: Lacks specific genetic abnormalities; involves various mutations leading to unchecked T-cell growth and survival.
  * Morphology: Pleomorphic T cells with variable patterns of infiltration.
  * Clinical: General symptoms include lymphadenopathy, skin rashes, and systemic symptoms.
* **Mycosis fungoides / SÃ©zary syndrome**
  * Concept: Mycosis fungoides is a type of cutaneous T-cell lymphoma that primarily affects the skin; SÃ©zary syndrome is the leukemic phase of this disease.
  * Pathogenesis: Clonal expansion of malignant T cells which migrate to the skin.
  * Morphology: Infiltration of the skin by atypical lymphocytes with cerebriform nuclei.
  * Clinical: Mycosis fungoides presents as patches, plaques, or tumors on the skin, while SÃ©zary syndrome includes erythroderma, lymphadenopathy, and atypical T cells in the blood.
{: .notice--info}

### Other Hematopoietic Tumors / ä»–ã®é€ è¡€å™¨è…«ç˜

* **Myelodysplastic syndrome**
  * Concept: A group of disorders caused by poorly formed or dysfunctional blood cells due to a disruption in the bone marrow.
  * Pathogenesis: Typically involves genetic mutations that affect the maturation of blood cells.
  * Morphology: Dysplasia in one or more types of blood cells; abnormal cell shapes and sizes in bone marrow.
  * Clinical: Symptoms often include anemia, fatigue, and increased risk of infections; can progress to acute myeloid leukemia.
* **Polycythemia vera**
  * Concept: A blood cancer characterized by an abnormal increase in red blood cells due to overactive bone marrow.
  * Pathogenesis: Most commonly caused by a mutation in the JAK2 gene.
  * Morphology: Elevated red cell mass with increased hematocrit and hemoglobin levels.
  * Clinical: Symptoms include headaches, dizziness, and a ruddy complexion; risk of thrombosis is elevated.
* **Essential thrombocythemia**
  * Concept: A chronic myeloproliferative disorder characterized by an excessive production of platelets.
  * Pathogenesis: Frequently associated with mutations in the JAK2, CALR, or MPL genes.
  * Morphology: Persistent thrombocytosis with large and morphologically abnormal platelets.
  * Clinical: Increased risk of clotting and bleeding, headache, and visual disturbances.
* **Primary myelofibrosis**
  * Concept: A myeloproliferative neoplasm marked by the replacement of the bone marrow with fibrous tissue.
  * Pathogenesis: Involves mutations in JAK2, CALR, or MPL that lead to abnormal proliferation of marrow fibroblasts.
  * Morphology: Bone marrow fibrosis with extramedullary hematopoiesis.
  * Clinical: Anemia, splenomegaly, fatigue, and fullness in the abdomen.
* **Multiple myeloma**
  * Concept: A cancer of plasma cells that produce abnormal antibodies.
  * Pathogenesis: Characterized by clonal proliferation of malignant plasma cells in bone marrow.
  * Morphology: Plasma cells with atypical morphology in bone marrow; presence of monoclonal protein in serum or urine.
  * Clinical: Bone pain, renal failure, hypercalcemia, and anemia.
* **MGUS**
  * Concept: A precursor condition to multiple myeloma characterized by the presence of abnormal plasma cells and a monoclonal protein in the blood.
  * Pathogenesis: The cause is not well understood; does not always progress to myeloma.
  * Morphology: Presence of monoclonal protein in serum without other features of plasma cell neoplasms.
  * Clinical: Usually asymptomatic; detected incidentally during blood tests.
* **WaldenstrÃ¶m macroglobulinemia**
  * Concept: A rare type of cancer involving the production of large amounts of macroglobulin antibody by B cells.
  * Pathogenesis: Lymphoplasmacytic lymphoma producing IgM monoclonal protein.
  * Morphology: Infiltration of the bone marrow with small lymphocytes and plasma cells.
  * Clinical: Symptoms include hyperviscosity, leading to neurological symptoms and bleeding.
* **Langerhans cell histiocytosis**
  * Concept: A disorder characterized by the proliferation of Langerhans cells, which are specialized dendritic cells.
  * Pathogenesis: May be a reactive or neoplastic process, often involving mutations in the BRAF gene.
  * Morphology: Accumulation and infiltration of Langerhans cells with eosinophilic granuloma formation.
  * Clinical: Can present as bone lesions, skin rash, or pulmonary disease, depending on the extent of the disease.
* **Hemophagocytic syndrome**
  * Concept: A severe, often fatal syndrome characterized by excessive activation of macrophages and T cells leading to cytokine overproduction and widespread tissue damage.
  * Pathogenesis: Can be primary (genetic) or secondary to infections, malignancies, or autoimmune diseases.
  * Morphology: Evidence of hemophagocytosis in bone marrow or other tissues.
  * Clinical: High fevers, cytopenias, hepatosplenomegaly, and neurological symptoms.
{: .notice--info}

### Other Hematopoietic Tumors / ä»–ã®é€ è¡€å™¨è…«ç˜

* **Myelodysplastic syndrome**
  * Concept: A group of disorders caused by poorly formed or dysfunctional blood cells due to a disruption in the bone marrow.
  * Pathogenesis: Typically involves genetic mutations that affect the maturation of blood cells.
  * Morphology: Dysplasia in one or more types of blood cells; abnormal cell shapes and sizes in bone marrow.
  * Clinical: Symptoms often include anemia, fatigue, and increased risk of infections; can progress to acute myeloid leukemia.
* **Polycythemia vera**
  * Concept: A blood cancer characterized by an abnormal increase in red blood cells due to overactive bone marrow.
  * Pathogenesis: Most commonly caused by a mutation in the JAK2 gene.
  * Morphology: Elevated red cell mass with increased hematocrit and hemoglobin levels.
  * Clinical: Symptoms include headaches, dizziness, and a ruddy complexion; risk of thrombosis is elevated.
* **Essential thrombocythemia**
  * Concept: A chronic myeloproliferative disorder characterized by an excessive production of platelets.
  * Pathogenesis: Frequently associated with mutations in the JAK2, CALR, or MPL genes.
  * Morphology: Persistent thrombocytosis with large and morphologically abnormal platelets.
  * Clinical: Increased risk of clotting and bleeding, headache, and visual disturbances.
* **Primary myelofibrosis**
  * Concept: A myeloproliferative neoplasm marked by the replacement of the bone marrow with fibrous tissue.
  * Pathogenesis: Involves mutations in JAK2, CALR, or MPL that lead to abnormal proliferation of marrow fibroblasts.
  * Morphology: Bone marrow fibrosis with extramedullary hematopoiesis.
  * Clinical: Anemia, splenomegaly, fatigue, and fullness in the abdomen.
* **Multiple myeloma**
  * Concept: A cancer of plasma cells that produce abnormal antibodies.
  * Pathogenesis: Characterized by clonal proliferation of malignant plasma cells in bone marrow.
  * Morphology: Plasma cells with atypical morphology in bone marrow; presence of monoclonal protein in serum or urine.
  * Clinical: Bone pain, renal failure, hypercalcemia, and anemia.
* **MGUS**
  * Concept: A precursor condition to multiple myeloma characterized by the presence of abnormal plasma cells and a monoclonal protein in the blood.
  * Pathogenesis: The cause is not well understood; does not always progress to myeloma.
  * Morphology: Presence of monoclonal protein in serum without other features of plasma cell neoplasms.
  * Clinical: Usually asymptomatic; detected incidentally during blood tests.
* **WaldenstrÃ¶m macroglobulinemia**
  * Concept: A rare type of cancer involving the production of large amounts of macroglobulin antibody by B cells.
  * Pathogenesis: Lymphoplasmacytic lymphoma producing IgM monoclonal protein.
  * Morphology: Infiltration of the bone marrow with small lymphocytes and plasma cells.
  * Clinical: Symptoms include hyperviscosity, leading to neurological symptoms and bleeding.
* **Langerhans cell histiocytosis**
  * Concept: A disorder characterized by the proliferation of Langerhans cells, which are specialized dendritic cells.
  * Pathogenesis: May be a reactive or neoplastic process, often involving mutations in the BRAF gene.
  * Morphology: Accumulation and infiltration of Langerhans cells with eosinophilic granuloma formation.
  * Clinical: Can present as bone lesions, skin rash, or pulmonary disease, depending on the extent of the disease.
* **Hemophagocytic syndrome**
  * Concept: A severe, often fatal syndrome characterized by excessive activation of macrophages and T cells leading to cytokine overproduction and widespread tissue damage.
  * Pathogenesis: Can be primary (genetic) or secondary to infections, malignancies, or autoimmune diseases.
  * Morphology: Evidence of hemophagocytosis in bone marrow or other tissues.
  * Clinical: High fevers, cytopenias, hepatosplenomegaly, and neurological symptoms.
{: .notice--info}

### Bleeding Disorder / å‡ºè¡€æ€§ç–¾æ‚£

* **Immune thrombocytopenic purpura**
  * Concept: An autoimmune disorder characterized by the destruction of platelets by antibodies, leading to bleeding and easy bruising.
  * Pathogenesis: Autoantibodies target platelet antigens, leading to their destruction in the spleen.
  * Morphology: Low platelet count with otherwise normal appearing platelets and bone marrow.
  * Clinical: Presents with petechiae, bruising, bleeding gums, and in severe cases, internal bleeding.
* **Thrombotic thrombocytopenic purpura**
  * Concept: A rare disorder that causes blood clots to form in small blood vessels throughout the body, leading to low platelet counts.
  * Pathogenesis: Deficiency or inhibition of ADAMTS13 (a von Willebrand factor-cleaving protease), leading to unusually large von Willebrand factor multimers that promote clotting.
  * Morphology: Thrombocytopenia and schistocytes (fragmented red cells) seen on blood smear.
  * Clinical: Symptoms include microangiopathic hemolytic anemia, renal failure, fever, and neurological symptoms.
* **Hemolytic uremic syndrome**
  * Concept: Typically follows an infection, particularly by E. coli O157:H7, leading to acute renal failure, hemolytic anemia, and thrombocytopenia.
  * Pathogenesis: Destruction of red blood cells, damage to kidney vessels, and low platelets due to toxins released by bacteria.
  * Morphology: Presence of schistocytes on blood smear, loss of renal function.
  * Clinical: Symptoms include bloody diarrhea, reduced urine output, pallor, and fatigue.
* **Disseminated intravascular coagulation**
  * Concept: A complex disorder that involves the overactivation of blood clotting in the small blood vessels, leading to widespread clots and bleeding due to consumption of clotting factors.
  * Pathogenesis: Triggered by severe infections, trauma, cancer, or obstetric complications.
  * Morphology: Presence of microthrombi in various organs and consumption of platelets and coagulation factors.
  * Clinical: Simultaneous bleeding and clotting, organ failure, shock.
* **Vitamin K deficiency**
  * Concept: Vitamin K is essential for the synthesis of several clotting factors; deficiency leads to impaired clotting and bleeding.
  * Pathogenesis: Can occur due to inadequate dietary intake, malabsorption, or interference by medications like antibiotics or anticoagulants.
  * Morphology: Prolongation of prothrombin time and decreased levels of vitamin K-dependent clotting factors.
  * Clinical: Easy bruising, bleeding gums, nosebleeds, and other bleeding manifestations.
* **Hemophilia**
  * Concept: A genetic disorder where blood doesn't clot normally due to deficiency or dysfunction of clotting factors (Factor VIII in Hemophilia A, Factor IX in Hemophilia B).
  * Pathogenesis: X-linked recessive disorder predominantly affecting males.
  * Morphology: Prolonged clotting times and reduced levels of specific clotting factors.
  * Clinical: Recurrent and prolonged bleeding, especially into joints and muscles; severity varies based on factor levels.
* **Von Willebrand disease**
  * Concept: The most common hereditary bleeding disorder, caused by a deficiency or dysfunction of von Willebrand factor (vWF), which helps platelets to stick to injured blood vessel walls and binds factor VIII.
  * Pathogenesis: Hereditary; types vary by vWF levels and function.
  * Morphology: Reduced vWF antigen and activity; normal or near-normal platelet count.
  * Clinical: Mucosal bleeding, easy bruising, excessive menstrual bleeding.
* **Bernard-Soulier syndrome**
  * Concept: A rare inherited disorder characterized by a deficiency of glycoprotein Ib, the receptor for vWF, leading to large but dysfunctional platelets.
  * Pathogenesis: Genetic mutations affect platelet adhesion.
  * Morphology: Large platelets and reduced platelet count.
  * Clinical: Severe bleeding, typically presenting in infancy or early childhood.
* **Glanzmann Thrombasthenia**
  * Concept: A rare genetic platelet disorder where the platelet glycoprotein IIb/IIIa complex, necessary for platelet aggregation, is either absent or dysfunctional.
  * Pathogenesis: Autosomal recessive inheritance of mutations in the genes encoding the glycoprotein complex.
  * Morphology: Normal platelet count but impaired function.
  * Clinical: Symptoms include mucocutaneous bleeding such as from the gums, nose, and gastrointestinal tract.
{: .notice--info}

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Red Blood Cell Abnormalities / èµ¤è¡€çƒç³»ã®ç•°å¸¸

## White Blood Cell Abnormalities / ç™½è¡€çƒç³»ã®ç•°å¸¸

## Hemostasis and Coagulation Abnormalities / æ­¢è¡€ãƒ»å‡å›ºç³»ã®ç•°å¸¸

# Rheumatology and Immunology / å…ç–«ãƒ»è† åŸç—…å†…ç§‘

## Immunology / å…ç–«å­¦

## Pathology / ç—…ç†

### Vasculitis / è¡€ç®¡ç‚
Giant cell arteritis \\
Takayasu arteritis \\
Polyarteritis nodosa \\
Kawasaki disease \\
Buerger disease \\
Granulomatosis with polyangiitis \\
Eosinophilic granulomatosis with polyangiitis \\
Microscopic polyangiitis \\
IgA vasculitis \\
Infectious vasculitis

## Pharmacology / è–¬ç†

### Immunosuppressant / å…ç–«æŠ‘åˆ¶å‰¤
Calcineurin inhibitor: Cyclosporine, tacrolimus \\
mTOR inhibitor: Sirolimus \\
Antimetabolite: Azathioprine, leflunomide, mycophenolate mofetil \\
JAK inhibitor: Tofacitinib \\
TNFÎ± inhibitor: Infiliximab, adalimumab, certolizumab, golimumab, etanercept \\
IL-1 receptor antogonist: Anakinra \\
IL-6 receptor antagonist: Tocilizumab \\
T-cell constimulation blocker: Abatacept \\
IL-2 receptor antagonist: Basiliximab \\
Anti-integrin: Natalizumab \\


### Glucocorticoid / ç³–è³ªã‚³ãƒ«ãƒã‚³ã‚¤ãƒ‰
Glucocorticoid: Hydrocortisone, cortisone, prednisolone, methylprednisolone, triamcinolone, betamethasone, dexamethasone

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Immunodeficiency / å…ç–«ä¸å…¨

## Allergy / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼

## Connective Tissue Disease / è† åŸç—…

# Infectious Diseases / æ„ŸæŸ“ç—‡å†…ç§‘

## Microbiology / å¾®ç”Ÿç‰©å­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Bacterial Infections / ç´°èŒæ„ŸæŸ“ç—‡

## Viral Infections / ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

## Fungal Infections / çœŸèŒæ„ŸæŸ“ç—‡

## Parasitic Infections / å¯„ç”Ÿè™«æ„ŸæŸ“ç—‡

# Neurology / ç¥çµŒå†…ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Cerebrovascular disorders / è„³è¡€ç®¡ç–¾æ‚£

## Dementia disorders / èªçŸ¥ç—‡æ€§ç–¾æ‚£

## Demyelinating disorders / è„±é«„æ€§ç–¾æ‚£

## Degenerative disorders / å¤‰æ€§ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Muscle disorders / ç­‹ç–¾æ‚£

## Peripheral nerve disorders / æœ«æ¢¢ç¥çµŒç–¾æ‚£

## Functional seizure disorders / æ©Ÿèƒ½æ€§ç™ºä½œæ€§ç–¾æ‚£

## Neurocutaneous syndromes / æ¯æ–‘ç—‡

## Brain tumors / è„³è…«ç˜

## Head injuries / é ­éƒ¨å¤–å‚·

## Malformations / å¥‡å½¢

# Ophthalmology / çœ¼ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Refractive and accommodative abnormalities / å±ˆæŠ˜ãƒ»èª¿ç¯€ç•°å¸¸

## Eyelid and lacrimal system disorders / çœ¼ç¼ãƒ»æ¶™å™¨ç–¾æ‚£

## Conjunctival, corneal, and scleral disorders / çµè†œãƒ»è§’è†œãƒ»å¼·è†œç–¾æ‚£

## Uveal disorders / ã¶ã©ã†è†œç–¾æ‚£

## Retinal and vitreous disorders / ç¶²è†œãƒ»ç¡å­ä½“ç–¾æ‚£

## Optic nerve disorders / è¦–ç¥çµŒç–¾æ‚£

## Lens disorders / æ°´æ™¶ä½“ç–¾æ‚£

## Glaucoma / ç·‘å†…éšœ

## Ocular trauma / çœ¼å¤–å‚·

# Otolaryngology / è€³é¼»å’½å–‰ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Inner ear disorders / å†…è€³ç–¾æ‚£

## Middle ear disorders / ä¸­è€³ç–¾æ‚£

## Outer ear disorders / å¤–è€³ç–¾æ‚£

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Nasal and sinus disorders / é¼»è…”ãƒ»å‰¯é¼»è…”ç–¾æ‚£

## Oral, tonsil, and salivary gland disorders / å£è…”ãƒ»æ‰æ¡ƒãƒ»å”¾æ¶²è…ºç–¾æ‚£

## Pharyngeal and laryngeal disorders / å’½é ­ãƒ»å–‰é ­ç–¾æ‚£

# Dermatology / çš®è†šç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Retinoic Acid Derivative / ãƒ¬ãƒãƒã‚¤ãƒ‰
Retinoic acid: Tretinoin, isotretinoin, adapaline, acitretin, tazarotene

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Eczema and dermatitis group / æ¹¿ç–¹ãƒ»çš®è†šç‚ç¾¤

## Urticaria and itching group / è•éº»ç–¹ãƒ»æ»ç—’ç¾¤

## Erythema / ç´…æ–‘ç—‡

## Bullous diseases / æ°´ç–±ç—‡

## Pustular diseases / è†¿ç–±ç—‡

## Pigmentation disorders / è‰²ç´ ç•°å¸¸ç—‡

## Nevus / æ¯æ–‘ç—‡

## Keratosis disorders / è§’åŒ–ç•°å¸¸

## Benign tumors / è‰¯æ€§è…«ç˜

## Malignant tumors / æ‚ªæ€§è…«ç˜

## Metabolic disorders / ä»£è¬ç•°å¸¸

# Orthopedic Surgery / æ•´å½¢å¤–ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Calcium Homeostasis / ã‚«ãƒ«ã‚·ã‚¦ãƒ æ’å¸¸æ€§
Bisphosphonate: Alendronate, risedronate, ibandronate, pamidronate, zoledronate \\
RANKL inhibitor: Denosumab \\
Selective estrogen receptor modulator: Raloxifene \\
Parathyroid hormone: Teriparatide, abaloparatide \\
Calcitonin: Calcitonin \\
Calcimimetic: Cinacalcet \\
Vitamin D: Cholecalciferol, calcifediol, calcitriol, ergocalciferol, doxercalciferol, paricalcitol, calcipotriene \\
Calcium supplement: Calcium

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Fractures / éª¨æŠ˜

## Dislocations / è„±è‡¼

## Spinal cord and spinal disorders / è„Šæ¤ãƒ»è„Šé«„ç–¾æ‚£

## Upper limb disorders / ä¸Šè‚¢ã®ç–¾æ‚£

## Lower limb disorders / ä¸‹è‚¢ã®ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Peripheral nerve injuries / æœ«æ¢¢ç¥çµŒæå‚·

## Metabolic bone disorders / ä»£è¬æ€§éª¨ç–¾æ‚£

## Tumors / è…«ç˜

# Urology / æ³Œå°¿å™¨ç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Gonadal Hormone /  ç”Ÿæ®–è…ºãƒ›ãƒ«ãƒ¢ãƒ³
Androgen: Testosterone, testosterone enanthate, testosterone cypionate, methyltestosterone, fluoxymesterone, oxymetholone, nandrolone, oxandrolone \\
5Î±-Reductase inhibitor: Finasteride, dutasteride

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Infections / æ„ŸæŸ“ç—‡

## Tumors / è…«ç˜

## Male Genital Disorders / ç”·æ€§å™¨ç–¾æ‚£

## Sexual Dysfunction / æ€§æ©Ÿèƒ½éšœå®³

# Obstetrics and Gynecology / ç”£ç§‘å©¦äººç§‘

## Anatomy / è§£å‰–

## Physiology / ç”Ÿç†

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

### Gonadal Hormones /  ç”Ÿæ®–è…ºãƒ›ãƒ«ãƒ¢ãƒ³
Estrogen: Estradiol, estradiol cypionate, estradiol valerate, ethinyl estradiol \\
Progestin: Progesterone, medroxyprogesterone acetate, norethindrone, levonorgestrel, megestrol \\
Selective estrogen receptor modulator: Clomiphene \\
Pituitary gonadotropin inhibitor: Danazol \\
Progestational antagonist: Mifepristone

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Menstrual abnormalities / æœˆçµŒã®ç•°å¸¸

## Abnormalities in sexual differentiation and genital morphology / æ€§åˆ†åŒ–ã¨æ€§å™¨å½¢æ…‹ã®ç•°å¸¸

## Genital inflammation and sexually transmitted infections / æ€§å™¨ã®ç‚ç—‡ãƒ»æ€§æ„ŸæŸ“ç—‡

## Infertility / ä¸å¦Š

## Age-related changes / åŠ é½¢ã«ä¼´ã†å¤‰åŒ–

## Benign tumors, pre-cancerous lesions, and neoplasms / é¡è…«ç˜ç—…å¤‰ãƒ»å‰ç™Œç—…å¤‰ãƒ»è…«ç˜

## Abnormalities in pregnancy / å¦Šå¨ ã®ç•°å¸¸

## Complicated pregnancies and mother-child infections / åˆä½µç—‡å¦Šå¨ ãƒ»æ¯å­æ„ŸæŸ“

## Abnormalities in childbirth / åˆ†å¨©ã®ç•°å¸¸

## Postpartum period / ç”£è¤¥

# Pediatrics / å°å…ç§‘

## Embryology / ç™ºç”Ÿå­¦

## Biochemistry / ç”ŸåŒ–å­¦

## Pathology / ç—…ç†

## Pharmacology / è–¬ç†

## Symptoms / ç—‡å€™

## Tests / æ¤œæŸ»

## Treatment / æ²»ç™‚

## Neonates / æ–°ç”Ÿå…

## Congenital abnormalities / å…ˆå¤©ç•°å¸¸

## Gastrointestinal disorders / æ¶ˆåŒ–å™¨ç–¾æ‚£

## Cardiovascular disorders / å¾ªç’°å™¨ç–¾æ‚£

## Respiratory disorders / å‘¼å¸å™¨ç–¾æ‚£

## Renal and urological disorders / è…ãƒ»æ³Œå°¿å™¨ç–¾æ‚£

## Metabolic and endocrine disorders / ä»£è¬ãƒ»å†…åˆ†æ³Œç–¾æ‚£

## Hematological and hematopoietic disorders / è¡€æ¶²ãƒ»é€ è¡€å™¨ç–¾æ‚£

## Immune and allergic disorders / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“ç—‡

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Tumors / è…«ç˜

# Psychiatry / ç²¾ç¥ç§‘

# Anesthesiology / éº»é…”ç§‘

# Radiology / æ”¾å°„ç·šç§‘

# Emergency Medicine / æ•‘æ€¥ç§‘